Clene (CLNN)
(Delayed Data from NSDQ)
$4.49 USD
+0.16 (3.70%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $4.34 -0.15 (-3.34%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Income Statements
Fiscal Year end for Clene Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1 | 0 | 1 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 1 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 41 | 49 | 50 | 20 | 1 |
Income After Depreciation & Amortization | -41 | -48 | -50 | -20 | -1 |
Non-Operating Income | -4 | 22 | 41 | 2 | 1 |
Interest Expense | 5 | 3 | 1 | 1 | 0 |
Pretax Income | -50 | -30 | -10 | -19 | 0 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -50 | -30 | -10 | -19 | 0 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -50 | -30 | -10 | -19 | 0 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -39 | -47 | -49 | -19 | -1 |
Depreciation & Amortization (Cash Flow) | 2 | 1 | 1 | 1 | 0 |
Income After Depreciation & Amortization | -41 | -48 | -50 | -20 | -1 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 5.25 | 3.26 | 3.08 | 0.88 | 0.11 |
Diluted EPS Before Non-Recurring Items | -6.60 | -14.60 | -12.20 | -24.60 | -4.20 |
Diluted Net EPS (GAAP) | -9.40 | -9.20 | -3.20 | -22.00 | -4.20 |
Fiscal Year end for Clene Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 0.07 | 0.17 | 0.11 | 0.27 |
Cost Of Goods | NA | 0.02 | 0.04 | 0.01 | 0.07 |
Gross Profit | NA | 0.06 | 0.13 | 0.10 | 0.20 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 9.29 | 10.06 | 9.64 | 10.54 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -9.23 | -9.93 | -9.54 | -10.34 |
Non-Operating Income | NA | -0.60 | 0.96 | 8.31 | -13.70 |
Interest Expense | NA | 1.24 | 1.20 | 1.19 | 1.10 |
Pretax Income | NA | -11.08 | -10.17 | -2.42 | -25.14 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -11.08 | -10.17 | -2.42 | -25.14 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -11.08 | -10.17 | -2.42 | -25.14 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 6.42 | 8.48 | 6.42 | 4.30 |
Diluted EPS Before Non-Recurring Items | NA | -1.80 | -1.20 | -0.40 | -2.40 |
Diluted Net EPS (GAAP) | NA | -1.80 | -0.20 | -0.40 | -5.80 |